PMP Awareness - research

PMP Awareness Organization

RESEARCH

HOME ::

RESEARCH

We hope this collective research helps others digging for much needed information. If you have a document or research paper you would like to add, please let us know.

*Click here for some very interesting abstracts:* Most recent documents are listed first:
2009
Long-Term Survival in Patients with Pseudomyxoma Peritonei Treated with Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy: 10 Years of Experience from a Single Institution Incidence, Risk Factors, and Impact of Severe Neutropenia After Hyperthermic Intraperitoneal Mitomycin C Management of appendiceal pseudomyxoma peritonei diagnosed during pregnancy Using Pharmacologic Data to Plan Clinical Treatments for Patients with Peritoneal Surface Malignancy Interstitial pneumonitis following intrapleural chemotherapy Pseudomyxoma Peritonei: A Need to Establish Evidence-Based Standard of Care—Is This the Right Trial? The Second Procedure Combining Complete Cytoreductive Surgery and Intraperitoneal Chemotherapy for Isolated Peritoneal Recurrence: Postoperative Course and Long-Term Outcome Critical Analysis of 33 Patients with Peritoneal Carcinomatosis Secondary to Colorectal and Appendiceal Signet Ring Cell Carcinoma Safety of Gastric Resections During Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis Incidence, Risk Factors, and Impact of Severe Neutropenia After Hyperthermic Intraperitoneal Mitomycin C 18F-FDG-PET/CT to Select Patients with Peritoneal Carcinomatosis for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
2008
Gene Testing Predicts Response to Erbitux Update on Chemotherapeutic Agents Utilized for Perioperative Intraperitoneal Chemotherapy Survival and Health Outcomes After CRS with IPHC for Disseminated Peritoneal Cancer of Appendiceal Origin Pseudomyxoma Peritonei: Is Disease Progression Related to Microbial Agents? A Study of Bacteria, MUC2 and MUC5AC Expression in Disseminated Peritoneal Adenomucinosis and Peritoneal Mucinous Carcinomatosis The Randomized Trial of CRS with HIPEC: What It Does and Does Not Tell Us HIPEC: The Complexities of Clinical Trials Current status and future strategies of cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis Cytoreduction and hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal carcinomatosis from pseudomyxoma peritonei A phase II study evaluating the use of concurrent mitomycin C and capecitabine in patients with advanced unresectable pseudomyxoma peritonei Hyperthermic Intraperitoneal Chemotherapy with Oxaliplatin for Peritoneal Carcinomatosis Arising from Appendix: Preliminary Results of a Survival Analysis VEGF Expression Predicts Survival in Patients with Peritoneal Surface Metastases from Mucinous Adenocarcinoma of the Appendix and Colon Swedish Experience with Peritonectomy and HIPEC. HIPEC in Peritoneal Carcinomatosis Pharmacokinetics of Oxaliplatin During Open Versus Laparoscopically Assisted Heated Intraoperative Intraperitoneal Chemotherapy (HIPEC): An Experimental Study Discordant Histology of Primary Appendiceal Adenocarcinoid Neoplasms with Peritoneal Dissemination Phase I Trial of Pegylated Liposomal Doxorubicin with Hyperthermic Intraperitoneal Chemotherapy in Patients Undergoing Cytoreduction for Advanced Intra-abdominal Malignancy
2007
Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Colorectal Carcinomatosis: If at First You Don’t Succeed..., Advances in Peritoneal Surface Oncology (Book) Progression of Pseudomyxoma Peritonei after Combined Modality Treatment: Management and Outcome Appendiceal Carcinoma with Peritoneal Dissemination: Outcomes for the Best of the Best Survival Analysis of Pseudomyxoma Peritonei Patients Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Mucinous Appendiceal Neoplasms: Preoperative MR Staging and Classification Compared with Surgical and Histopathologic Findings Pseudomyxoma Peritonei: Clinical Pathological and Biological Prognostic Factors in Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Prognostic Value of Circulating Tumor Markers in Patients with Pseudomyxoma Peritonei Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Critical Analysis of Treatment Failure After Complete Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Peritoneal Dissemination From Appendiceal Mucinous Neoplasms Learning Curve for Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Peritoneal Surface Malignancy—A Journey to Becoming a Nationally Funded Peritonectomy Center Incidence of Postoperative Pancreatic Fistula and Hyperamylasemia after Cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy Impact of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy on Systemic Toxicity Optimization of Hyperthermic Intraperitoneal Chemotherapy With Oxaliplatin Plus Irinotecan at 43C After Compete Cytoreductive Surgery: Mortality and Morbidity in 106 Consecutive Patients
2006
New standard of Care for Appendiceal Neoplasms and PMP Intergel for the prevention of adhesions following abdominal surgery Perioperative intraperitoneal chemotherapy for peritoneal surface malignancy Management of PMP Decision Making and Technical Factors Account for the Learning Curve in Complex Surgery HIPEC consensus statement Pseudomyxoma Peritonei: 5th International Workshop Prospective Morbidity and Mortality Assessment of Cytoreductive Surgery Plus Perioperative Intraperitoneal Chemotherapy To Treat Peritoneal Dissemination of Appendiceal Mucinous Malignancy Cytoreductive Surgery Followed by Intraperitoneal Hyperthermic Perfusion Analysis of Morbidity and Mortality in 209 Peritoneal Surface Malignancies Treated with Closed Abdomen Technique A specific cadherin phenotype may characterise the disseminating yet non-metastatic behaviour of pseudomyxoma peritonei A Systematic Review on the Efficacy of Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei Analysis of Loss of Heterozygosity for Tumor-Suppressor Genes Can Accurately Classify and Predict the Clinical Behavior of Mucinous Tumors Arising From the Appendix Appendiceal Neoplasms With Peritoneal Dissemination: Outcomes After Cytoreductive Surgery and Intraperitoneal Hyperthermic Chemotherapy The ‘‘Alphabet Soup’’ of Peritoneal Dissemination From Appendiceal Neoplasms and Other Malignancies
2005
Management of peritoneal carcinomatosis from colon cancer, Gastric cancer and appendix malignancy Update on chemotherapeutic agents utilized for Perioperative IntraPeritoneal Chemotherapy Are there curative options to peritoneal carcinomatosis? Celebrex prevents adhesions after surgery Prevention of intra-abdominal adhesions using the COX-2 inhibitor Celecobix Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer Bowel Complications in 203 Cases of Peritoneal Surface Malignancies Treated With Peritonectomy and Closed-Technique Intraperitoneal Hyperthermic Perfusion The doctor's doctor: Pseudomyxoma Peritonei Intraperitoneal Hyperthermic Chemotherapy for Peritoneal Surface Malignancy: Current Status and Future Directions
2004
PMP new management by cytoreductive surgery and IPHC Incomplete cytoreduction in 174 patients with Peritoneal Carcinomatosis from Appendiceal Malignancy Inflammation and cancer Peritoneal carcinomatosis treated with surgery and IPHC: 14 year experience Gastrointestinal PMP: images Cytoreductive Surgery + IPHC: A multi-institutional study of 506 patients PMP-role of cytoreduction and IPHC Seprafilm efficacy Peritonectomy and Intraperitoneal Hyperthermic Perfusion (IPHP): A Strategy That Has Confirmed its Efficacy in Patients with Pseudomyxoma Peritonei Heated intra-operative intraperitoneal oxaliplatin plus irinotecan after complete resection of peritoneal carcinomatosis Celebrex makes cancer cells self-destruct Lymph Node Metastasis in Epithelial Malignancies of the Appendix With Peritoneal Dissemination Does Not Reduce Survival in Patients Treated by Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy
2003
Carcinomatosis:Is cure an option? Randomized trial of CRS and IPHC vs Systemic Chemo and palliative surgery in patients with peritoneal carcinomatosis Clinical research to standard of care: when does the transition occur? PMP: a review of 62 cases Reduced Morbidity Following Cytoreductive Surgery and Intraperitoneal Hyperthermic Chemoperfusion Mucinous cystadenoma of the appendix Hyperthermia-Has its time come? Pseudomyxoma Peritonei Management of peritoneal carcinomatosis: Is an answer at hand? PMP: A controversial Disease Tips for Surgery Patients Peritonectomy plus IPHP for peritoneal carcinosis: presentation Surgery Combined With Peritonectomy & IPHC in Abdominal Cancers With Peritoneal Carcinomatosis: A Phase II Study Intraperitoneal drug delivery-rational and results Primary Neoplasms of the Appendix: Radiologic Spectrum of Disease with Pathologic Correlation Thermal Enhancement of New Chemotherapeutic Agents at Moderate Hyperthermia Factors Predicting Survival After Intraperitoneal Hyperthermic Chemotherapy With Mitomycin C After Cytoreductive Surgery for Patients With Peritoneal Carcinomatosis Follow up of patients treatmed by cytoreduction and IPHC for peritoneal carcinomatosis Pseudomyxoma peritonei treated with complete resection and immediate intraperitoneal chemotherapy
2002
Cyto and IP chemo for peritoneal carcinomatosis Pseudomyxoma Peritonei is a Disease of MUC 2 - Expressing Goblet cells Cytoreduction including total gastrectomy for PMP 5FU rat study for peritoneal metastases Sub pyloric space-important features of PMP Morbidity and mortality associated with IP Chemo for PMP 100 cases operability and early outcomes Appendix cancer mimicking ovarian cancer CTs in PMP: a review of 17 cases Management of malignant bowel obstruction Preoperative evaluation by MRI in patients with bowel obstruction Two novel orthotopic mouse models portray the PMCA-I histopathologic subtype Prognostic Value of Baseline and Serial Carcinoembryonic Antigen and Carbohydrate Antigen 19.9 Measurements in Patients With Pseudomyxoma Peritonei Treated With Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Heated intra-operative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmacokinetics and tissue distribution
2001
Review of a personal experience in the management of carcinomatosis and sarcomatosis Cytoreductive surgery & IPHC with mitomycinC Safety Monitoring of the Coliseum Technique for Heated Intraoperative Intraperitoneal Chemotherapy With Mitomycin C Rational and techniques of IPHC Second look surgery in patients with peritoneal dissemination from appendiceal malignancy Disseminated peritoneal adenomucinosis similar to panperitonitis Pedunculated polyps in PMP Is peritoneal carcinomatosis an incurable disease? Cytoreduction and peri-operative chemo as a curative approach to PMP Correspondence for PMP CT appearance of DPAM Patients with Pseudomyxoma Peritonei Associated with Disseminated Peritoneal Adenomucinosis Have a Significantly More Favorable Prognosis than Patients with Peritoneal Mucinous Carcinomatosis Histopathologic Analysis in 46 Patients with Pseudomyxoma Peritonei Syndrome: Failure versus Success with a Second-Look Operation Gelatinous Ascites: a study of pmp in 67 patients Decision making in palliative surgery
2000
Clinical presentation of PMP Pseudomyxoma Peritonei: Images in surgery CT findings of PMP Peritonectomy and hyperthermic antiblastic perfusion in peritoneal carcinomatosis Hemodynamic and Cardiac Function Parameters During Heated Intraoperative Intraperitoneal Chemotherapy Using the Open “Coliseum Technique” Peritoneal Carcinomatosis from Non-Gynecologic Malignancies Results of the EVOCAPE 1 Multicentric Prospective Study Intraperitoneal Chemohyperthermia with Mitomycin C for Digestive Tract Cancer Patients with Peritoneal Carcinomatosis Pleural Extension of Mucinous Tumor in Patients with Pseudomyxoma Peritonei Syndrome
1994-1999
Results of Treatment of 385 Patients With Peritoneal Surface Spread of Appendiceal Malignancy Molecular Genetic evidence supporting the clonality and appendiceal origin of PMP in women Morbidity and Mortality Analysis of 200 Treatments With Cytoreductive Surgery and Hyperthermic Intraoperative Intraperitoneal Chemotherapy Using the Coliseum Technique Intraperitoneal chemotherapy PMP Case Report Mucinous epithelial cysts of spleen associated with PMP Review:Pseudomyxoma Peritonei Retroperitonei PMP-a heterogenous disease Pulmonary metastases in PMP: Sugarbaker Laser ablation for PMP It's what the doctor doesn't see that kills the patient: Sugarbaker Analysis of mucinous cystadenoma of the appendix Patterns of failure with PMP of appendiceal origin PMP and the cytologist Therapy of PMP using Monoclonal Antibodies Successful pregnancy in PMP treated with cisplatin
Other documents
Letter to request insurance co HighBeam Research: Article:A woman's story-1998 Myths and facts about the hipaa privacy rule HighBeam Research: Article:David Morris-2005 Wikipedia Definition of Pseudomyxoma Peritonei Protocol for the treatment of patients with peritoneal surface malignancy with IPHC and EPIC: Sugarbaker Aggressive cancer treatment at St. Agnes Healthcare Audrey Hepburn